Efficacy of Artesunate Plus Amodiaquine versus That of Artemether-Lumefantrine for the Treatment of Uncomplicated Childhood Plasmodium falciparum Malaria in Zanzibar, Tanzania
Clinical Infectious Diseases2005Vol. 41(8), pp. 1079–1086
Citations Over TimeTop 1% of 2005 papers
Andreas Mårtensson, J.S. Stromberg, Christin Sisowath, Mwinyi Msellem, José Pedro Gil, Scott Montgomery, Piero Olliaro, Abdullah Ali, Anders Björkman
Abstract
Both treatments were highly efficacious, but AL provided stronger prevention against reinfection. The high proportion of recrudescences found after day 28 and the genetic selection by the long-acting partner drug underlines the importance of long follow-up periods in clinical trials. A long follow-up duration and performance of PCR genotyping should be implemented in programmatic surveillance of antimalarial drugs.
Related Papers
- → Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®)(2015)13 cited
- → The efficacies of artesunate–sulfadoxine–pyrimethamine and artemether–lumefantrine in the treatment of uncomplicated,Plasmodium falciparummalaria, in an area of low transmission in central Sudan(2006)24 cited
- → Repeated Treatment with Antimalarial Agents Causes In Vitro Liver Toxicity(2023)2 cited
- → Comparison of the efficacy of artemether-lumefantrine vs. artesunate plus sulfadoxine-pyrimethamine in children with uncomplicated falciparum malaria(2010)1 cited
- → A pooled analysis of the duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine(2019)2 cited